OECD Approves Toxys' ToxTracker for Global Test Guideline Programme, Advancing Animal-Free Genotoxicity Testing
Key Insights
Toxys (search) announces that its flagship ToxTracker (search) assay has been accepted into the OECD (search) Test Guidelines Programme following extensive multi-year international inter-laboratory validation.
The OECD (search) has published the draft ToxTracker (search) Test Guideline for public consultation, with full approval expected to unlock widespread regulatory acceptance across industries.
ToxTracker (search) is a unique stem cell-based reporter assay that accurately predicts genotoxic potency and provides insight into mode of action for pharmaceutical, chemical, and cosmetic safety testing.
Toxys (search), a Netherlands-based biotechnology company specializing in animal-free toxicology solutions, has achieved a major regulatory milestone with the acceptance of its flagship ToxTracker (search) assay into the Organization for Economic Co-operation and Development (OECD (search)) Test Guidelines Programme. This development marks a significant step toward global regulatory recognition and commercial expansion for the innovative genotoxicity testing platform.
Regulatory Pathway and Validation
The OECD (search) approval follows an extensive multi-year international inter-laboratory validation process that demonstrated ToxTracker (search)'s reliability and accuracy. The organization has now published the draft ToxTracker Test Guideline for public consultation, representing a crucial step in the formal approval process.
Full OECD (search) approval is expected to unlock widespread regulatory acceptance across multiple industries and regulatory bodies, enabling users to include genotoxicity data from ToxTracker (search) in their regulatory submissions. This regulatory endorsement positions the assay as a validated alternative to traditional animal-based testing methods.
Technology and Applications
ToxTracker (search) is an in vitro method that accurately predicts the genotoxic potency of substances through a unique stem cell-based reporter assay system. The technology provides reliable genotoxicity hazard identification while offering detailed insights into the mode of action of genotoxic compounds.
The assay can discriminate between direct DNA (search) reactivity and indirect genotoxicity related to oxidative stress or protein damage. Additionally, ToxTracker (search) can distinguish clastogens from aneugens through various assay extensions, including ToxTracker ACE, providing comprehensive mechanistic understanding that can help mitigate regulatory rejection risks.
Industry Impact and Applications
The ToxTracker (search) platform significantly improves in vitro safety assessment across multiple sectors, including novel pharmaceutical products, agrochemicals, chemicals, cosmetics, and food-related products. The assay is already being incorporated by various industries into their regulatory applications, demonstrating its practical utility in real-world safety testing scenarios.
"OECD (search)'s endorsement of ToxTracker (search) is a transformative moment for Toxys (search) and the future of toxicology," said Giel Hendriks, CEO of Toxys. "It validates our scientific approach and opens the door to global regulatory markets. We remain committed to delivering innovative, animal-free safety solutions that meet the highest standards of reliability and ethics."
Advancing Animal-Free Testing
The OECD (search) endorsement confirms ToxTracker (search)'s positioning in next-generation genotoxicity testing and aligns with strong international pressure and ambitions to reduce animal testing. This development represents a significant advancement in the field of alternative testing methods, providing industries with a scientifically validated tool that eliminates the need for animal-based genotoxicity studies.
Toxys (search) develops advanced in vitro assays designed to identify toxic, carcinogenic, and reproductive toxicological properties of chemicals early in development, supporting the broader industry shift toward more ethical and efficient testing methodologies.